Baby Safety / Compounds / MDMA (3,4-Methylenedioxymethamphetamine)

Is MDMA (3,4-Methylenedioxymethamphetamine) safe for babies and kids?

Very high risk for kids

Infants are more vulnerable to MDMA (3,4-Methylenedioxymethamphetamine) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is mdma (3,4-methylenedioxymethamphetamine)?

The IUPAC name is 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine.

Also known as: 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine, MDMA, Ecstasy, 3,4-methylenedioxymethamphetamine.

IUPAC name
1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine
CAS number
42542-10-9
Molecular formula
C11H15NO2
Molecular weight
193.24 g/mol
SMILES
CC(CC1=CC2=C(C=C1)OCO2)NC
PubChem CID
1615

Risk for babies

Very high risk

Infants are more vulnerable to MDMA (3,4-Methylenedioxymethamphetamine) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of MDMA (3,4-Methylenedioxymethamphetamine), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

1 regulatory bodyhas classified MDMA (3,4-Methylenedioxymethamphetamine).

AgencyYearClassificationNotes
DEA—Schedule ICurrent regulatory status

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter mdma (3,4-methylenedioxymethamphetamine)

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to MDMA (3,4-Methylenedioxymethamphetamine):

  • Therapeutic alternatives (consult prescriber)
    Trade-offs: Drug-specific. Cannot substitute without medical guidance.
    Relative cost: 1.2-2×

Frequently asked questions

Is mdma (3,4-methylenedioxymethamphetamine) safe for kids?

Infants are more vulnerable to MDMA (3,4-Methylenedioxymethamphetamine) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain mdma (3,4-methylenedioxymethamphetamine)?

MDMA (3,4-Methylenedioxymethamphetamine) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to mdma (3,4-methylenedioxymethamphetamine)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See MDMA (3,4-Methylenedioxymethamphetamine) in the baby app

Look up products containing mdma (3,4-methylenedioxymethamphetamine), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (2)
  1. US DEA: MDMA (3,4-Methylenedioxymethamphetamine) — Schedule I Classification, FDA Breakthrough Therapy Designation for PTSD (2017), Phase 3 Trial Results, and Adulterant Contamination Concerns (2023) (2023) — regulatory
  2. NIDA Research Report: MDMA (Ecstasy/Molly) — Serotonergic Neurotoxicity, Hyperthermia, Hyponatremia (SIADH), Adolescent Vulnerability, CYP2D6 Pharmacogenomics, and Harm Reduction Strategies (2023) (2023) — academic

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →